APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiovascular and Cerebrovascular AI-assisted Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

6 March 2026184 pages

Choose your research edition.

Industry ResearchCardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cardiovascular and Cerebrovascular AI-assisted Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cardiovascular and Cerebrovascular AI-assisted Diagnosis include Deepwise, Lepu Medical, NeuMiva, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun and FOSUN AITROX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cardiovascular and Cerebrovascular AI-assisted Diagnosis and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cardiovascular and Cerebrovascular AI-assisted Diagnosis revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cardiovascular and Cerebrovascular AI-assisted Diagnosis market size, projected growth trends, production technologies, key applications, and end-use industries.

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Segment by Company

Deepwise

Lepu Medical

NeuMiva

G K Healthcare

Sense Time

United Imaging

Infervision

Shukun

FOSUN AITROX

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Segment by Type

Public Cloud

Private Cloud

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Segment by Application

Hospital

Clinic

Imaging Center

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular and Cerebrovascular AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular and Cerebrovascular AI-assisted Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cardiovascular and Cerebrovascular AI-assisted Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis industry.

Chapter 3: Detailed analysis of Cardiovascular and Cerebrovascular AI-assisted Diagnosis companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cardiovascular and Cerebrovascular AI-assisted Diagnosisrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Public Cloud Table 3. Key Players of Private Cloud Table 4. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Imaging Center Table 8. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Region (2021-2026) Table 11. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Region (2027-2032) Table 13. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Trends Table 14. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Drivers Table 15. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Opportunities and Challenges Table 16. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Restraints Table 17. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue Market Share by Company (2021-2026) Table 19. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Key Company Head Office and Area Served Table 21. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Company, Product Type & Application Table 22. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue Market Share by Type (2021-2026) Table 29. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue Market Share by Type (2027-2032) Table 30. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue Market Share by Application (2021-2026) Table 34. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue Market Share by Application (2027-2032) Table 35. Deepwise Company Information Table 36. Deepwise Business Overview Table 37. Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio Table 39. Deepwise Recent Development Table 40. Lepu Medical Company Information Table 41. Lepu Medical Business Overview Table 42. Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio Table 44. Lepu Medical Recent Development Table 45. NeuMiva Company Information Table 46. NeuMiva Business Overview Table 47. NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio Table 49. NeuMiva Recent Development Table 50. G K Healthcare Company Information Table 51. G K Healthcare Business Overview Table 52. G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio Table 54. G K Healthcare Recent Development Table 55. Sense Time Company Information Table 56. Sense Time Business Overview Table 57. Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio Table 59. Sense Time Recent Development Table 60. United Imaging Company Information Table 61. United Imaging Business Overview Table 62. United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio Table 64. United Imaging Recent Development Table 65. Infervision Company Information Table 66. Infervision Business Overview Table 67. Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio Table 69. Infervision Recent Development Table 70. Shukun Company Information Table 71. Shukun Business Overview Table 72. Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio Table 74. Shukun Recent Development Table 75. FOSUN AITROX Company Information Table 76. FOSUN AITROX Business Overview Table 77. FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio Table 79. FOSUN AITROX Recent Development Table 80. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026) & (US$ Million) Table 81. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032) & (US$ Million) Table 82. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026) & (US$ Million) Table 83. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032) & (US$ Million) Table 84. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026) Table 86. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032) Table 87. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026) & (US$ Million) Table 88. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032) & (US$ Million) Table 89. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026) & (US$ Million) Table 90. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032) & (US$ Million) Table 91. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026) Table 93. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032) Table 94. China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026) & (US$ Million) Table 95. China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032) & (US$ Million) Table 96. China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026) & (US$ Million) Table 97. China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026) & (US$ Million) Table 99. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032) & (US$ Million) Table 100. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026) & (US$ Million) Table 101. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026) Table 104. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032) Table 105. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026) & (US$ Million) Table 106. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032) & (US$ Million) Table 107. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026) & (US$ Million) Table 108. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032) & (US$ Million) Table 109. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026) Table 111. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Image Figure 2. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type: 2025 VS 2032 Figure 4. Public Cloud Image Figure 5. Private Cloud Image Figure 6. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Imaging Center Image Figure 11. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 13. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue Market Share by Type (2021-2032) Figure 20. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue Market Share by Application (2021-2032) Figure 22. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 23. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type (2021-2032) Figure 24. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application (2021-2032) Figure 25. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 26. United States Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 27. Canada Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 29. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 30. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type (2021-2032) Figure 31. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application (2021-2032) Figure 32. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 33. Germany Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 34. France Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 36. Italy Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 37. Russia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 39. China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 40. China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type (2021-2032) Figure 41. China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application (2021-2032) Figure 42. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 43. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type (2021-2032) Figure 44. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application (2021-2032) Figure 45. Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 46. Japan Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 50. India Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 51. Australia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 56. Brazil Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 61. UAE Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 63. Chile Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Public Cloud
  • Private Cloud
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Deepwise
  • Lepu Medical
  • NeuMiva
  • G K Healthcare
  • Sense Time
  • United Imaging
  • Infervision
  • Shukun
  • FOSUN AITROX

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Public Cloud
  5. 1.2.3 Private Cloud
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Imaging Center
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Growth Trends by Region
  13. 1.5.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Region (2021-2026)
  15. 1.5.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Dynamics
  1. 2.1 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Trends
  2. 2.2 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Drivers
  3. 2.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Opportunities and Challenges
  4. 2.4 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue by Company (2021-2026)
  2. 3.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Key Company Head office and Area Served
  4. 3.4 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Company, Product Type & Application
  5. 3.5 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Tier 1, Tier 2, and Tier 3
4 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market by Type
  1. 4.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2032)
  3. 4.3 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size Share by Type (2021-2032)
5 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market by Application
  1. 5.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2032)
  3. 5.3 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Deepwise
  2. 6.1.1 Deepwise Company Information
  3. 6.1.2 Deepwise Business Overview
  4. 6.1.3 Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
  6. 6.1.5 Deepwise Recent Developments
  7. 6.2 Lepu Medical
  8. 6.2.1 Lepu Medical Company Information
  9. 6.2.2 Lepu Medical Business Overview
  10. 6.2.3 Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
  12. 6.2.5 Lepu Medical Recent Developments
  13. 6.3 NeuMiva
  14. 6.3.1 NeuMiva Company Information
  15. 6.3.2 NeuMiva Business Overview
  16. 6.3.3 NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
  18. 6.3.5 NeuMiva Recent Developments
  19. 6.4 G K Healthcare
  20. 6.4.1 G K Healthcare Company Information
  21. 6.4.2 G K Healthcare Business Overview
  22. 6.4.3 G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
  24. 6.4.5 G K Healthcare Recent Developments
  25. 6.5 Sense Time
  26. 6.5.1 Sense Time Company Information
  27. 6.5.2 Sense Time Business Overview
  28. 6.5.3 Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
  30. 6.5.5 Sense Time Recent Developments
  31. 6.6 United Imaging
  32. 6.6.1 United Imaging Company Information
  33. 6.6.2 United Imaging Business Overview
  34. 6.6.3 United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
  36. 6.6.5 United Imaging Recent Developments
  37. 6.7 Infervision
  38. 6.7.1 Infervision Company Information
  39. 6.7.2 Infervision Business Overview
  40. 6.7.3 Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
  42. 6.7.5 Infervision Recent Developments
  43. 6.8 Shukun
  44. 6.8.1 Shukun Company Information
  45. 6.8.2 Shukun Business Overview
  46. 6.8.3 Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
  48. 6.8.5 Shukun Recent Developments
  49. 6.9 FOSUN AITROX
  50. 6.9.1 FOSUN AITROX Company Information
  51. 6.9.2 FOSUN AITROX Business Overview
  52. 6.9.3 FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
  54. 6.9.5 FOSUN AITROX Recent Developments
7 North America
  1. 7.1 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032)
  2. 7.2 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type
  3. 7.2.1 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026)
  4. 7.2.2 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032)
  5. 7.2.3 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type (2021-2032)
  6. 7.3 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application
  7. 7.3.1 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026)
  8. 7.3.2 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032)
  9. 7.3.3 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application (2021-2032)
  10. 7.4 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country
  11. 7.4.1 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026)
  13. 7.4.3 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032)
  14. 7.4.4 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032)
  2. 8.2 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type
  3. 8.2.1 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type (2021-2032)
  6. 8.3 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application
  7. 8.3.1 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application (2021-2032)
  10. 8.4 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country
  11. 8.4.1 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032)
  2. 9.2 China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type
  3. 9.2.1 China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026)
  4. 9.2.2 China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032)
  5. 9.2.3 China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type (2021-2032)
  6. 9.3 China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application
  7. 9.3.1 China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026)
  8. 9.3.2 China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032)
  9. 9.3.3 China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032)
  2. 10.2 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type
  3. 10.2.1 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type (2021-2032)
  6. 10.3 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application
  7. 10.3.1 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application (2021-2032)
  10. 10.4 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country
  11. 10.4.1 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst